ATE312086T1 - Phenoxazinanaloge zur behandlung von amyloidose - Google Patents

Phenoxazinanaloge zur behandlung von amyloidose

Info

Publication number: ATE312086T1
Authority: AT; Austria
Prior art keywords: hydrogen; lower alkyl; amyloidose; phenoxazine; analogues
Prior art date: 2000-09-29

Application number

AT01122733T

Other languages

English (en)

Inventor

Corinne Elizab Augelli-Szafran

Yingije Lai

Tomoyuki Yasunaga

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-29

Filing date

2001-09-21

Publication date

2005-12-15

2001-09-21 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2005-12-15 Application granted granted Critical

2005-12-15 Publication of ATE312086T1 publication Critical patent/ATE312086T1/de

Links

TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical class C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 title 1
206010002022 amyloidosis Diseases 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 3
150000002431 hydrogen Chemical class 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000003545 alkoxy group Chemical group 0.000 abstract 2
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
-1 cyano, carboxy Chemical group 0.000 abstract 2
125000004663 dialkyl amino group Chemical group 0.000 abstract 2
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical class 0.000 abstract 2
125000001072 heteroaryl group Chemical group 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
208000037259 Amyloid Plaque Diseases 0.000 abstract 1
102000009091 Amyloidogenic Proteins Human genes 0.000 abstract 1
108010048112 Amyloidogenic Proteins Proteins 0.000 abstract 1
238000004220 aggregation Methods 0.000 abstract 1
230000002776 aggregation Effects 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000003710 aryl alkyl group Chemical group 0.000 abstract 1
125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
125000002837 carbocyclic group Chemical group 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000005114 heteroarylalkoxy group Chemical group 0.000 abstract 1
125000004446 heteroarylalkyl group Chemical group 0.000 abstract 1
238000003384 imaging method Methods 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/38—[b, e]-condensed with two six-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Hospice & Palliative Care (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Psychiatry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT01122733T 2000-09-29 2001-09-21 Phenoxazinanaloge zur behandlung von amyloidose ATE312086T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US23696600P	2000-09-29	2000-09-29

Publications (1)

Publication Number	Publication Date
ATE312086T1 true ATE312086T1 (de)	2005-12-15

Family

ID=22891762

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01122733T ATE312086T1 (de)	2000-09-29	2001-09-21	Phenoxazinanaloge zur behandlung von amyloidose

Country Status (10)

Country	Link
US (1)	US20020143012A1 (de)
EP (1)	EP1193260B1 (de)
JP (1)	JP2002201186A (de)
AT (1)	ATE312086T1 (de)
BR (1)	BR0104344A (de)
CA (1)	CA2357450A1 (de)
DE (1)	DE60115569T2 (de)
DK (1)	DK1193260T3 (de)
ES (1)	ES2253315T3 (de)
MX (1)	MXPA01009768A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE602004026597D1 (de) *	2003-08-07	2010-05-27	Merck Sharp & Dohme	Behandlung von alzheimer-krankheit und verwandten zuständen
CN100447145C (zh) *	2003-08-18	2008-12-31	诺瓦提斯公司	适宜作为近红外显像剂的3h－吩嗪衍生物、其制备和用途
GB0410238D0 (en)	2004-05-07	2004-06-09	Merck Sharp & Dohme	Therapeutic agents
EP2081892A4 (de) *	2006-11-17	2014-03-05	Donald F Weaver	Verbindungen und verfahren zur behandlung von proteinfaltungserkrankungen
DK2890700T3 (en)	2012-08-28	2018-03-12	Univ Tuebingen Medizinische Fakultaet	HALOGENATED BENZOXAZINES AND THEIR USE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9506197D0 (en) *	1995-03-27	1995-05-17	Hoffmann La Roche	Inhibition of tau-tau association.
AP2002002387A0 (en) *	1999-06-10	2002-03-31	Warner Lambert Co	Method of inhibiting amyloid aggregation and imaging amyloid deposits.
YU86801A (sh) *	1999-06-10	2004-07-15	Warner-Lambert Company	Izoindol derivati korisni u inhibiciji agregacije amiloidnih proteina i snimanju amiloidnih naslaga

2001
- 2001-09-19 CA CA002357450A patent/CA2357450A1/en not_active Abandoned
- 2001-09-21 ES ES01122733T patent/ES2253315T3/es not_active Expired - Lifetime
- 2001-09-21 DE DE60115569T patent/DE60115569T2/de not_active Expired - Fee Related
- 2001-09-21 EP EP01122733A patent/EP1193260B1/de not_active Expired - Lifetime
- 2001-09-21 AT AT01122733T patent/ATE312086T1/de not_active IP Right Cessation
- 2001-09-21 DK DK01122733T patent/DK1193260T3/da active
- 2001-09-27 MX MXPA01009768A patent/MXPA01009768A/es unknown
- 2001-09-27 US US09/966,534 patent/US20020143012A1/en not_active Abandoned
- 2001-09-28 BR BR0104344-7A patent/BR0104344A/pt not_active IP Right Cessation
- 2001-09-28 JP JP2001301315A patent/JP2002201186A/ja not_active Abandoned

Also Published As

Publication number	Publication date
DK1193260T3 (da)	2006-04-10
DE60115569T2 (de)	2006-08-10
EP1193260B1 (de)	2005-12-07
MXPA01009768A (es)	2004-08-12
ES2253315T3 (es)	2006-06-01
DE60115569D1 (de)	2006-01-12
JP2002201186A (ja)	2002-07-16
CA2357450A1 (en)	2002-03-29
EP1193260A1 (de)	2002-04-03
BR0104344A (pt)	2003-03-05
US20020143012A1 (en)	2002-10-03

Similar Documents

Publication	Publication Date	Title
PT1184376E (pt)	2005-04-29	Novos derivados heterociclicos de carboxamida
DK0931788T3 (da)	2002-11-25	Metalloproteasehæmmere
EA200200976A1 (ru)	2003-02-27	Способ лечения или ингибирования полипов ободочной кишки
UA83243C2 (ru)	2008-06-25	Соединения, которые ингибируют натриезависимый переносчик глюкозы
GB0318343D0 (en)	2003-09-10	No title
NO20045369L (no)	2004-12-08	Nye, substituerte sulfamatanticonvulsivaderivater
EA200101133A1 (ru)	2002-06-27	Способ ингибирования агрегации амилоидных белков и визуализации амилоидных отложений с использованием производных изоиндолина
DE60012751D1 (de)	2004-09-09	Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
DE60330407D1 (de)	2010-01-14	Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung
DK0959906T3 (da)	2003-12-08	Delta 1,6 bicyclo[4,4,0] funktionelle farver til kontrastforøgelse ved optisk afbildning
DE50011034D1 (de)	2005-09-29	N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
BRPI0407841A (pt)	2006-11-14	inibidores heterocìclicos de quinase
WO2000076489A3 (en)	2002-05-30	Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
ATE380816T1 (de)	2007-12-15	Substituierte imidazopyrimidine zur prävention und behandlung von krebs
AU2001255646A1 (en)	2001-11-12	Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
EA200100090A2 (ru)	2001-08-27	Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
DE69423459D1 (de)	2000-04-20	Dihydrat des N-(4-Amino-6,7-dimethoxychinazol-2-yl)-N-methyl-N'-(tetrahydrofuroyl-2)-propylendiamin Hydrochlorids(=Alfuzosin Hydrochlorid Dihydrat) und ein Verfahren zur Herstellung
TR200302288T2 (tr)	2004-12-21	Terapi için yeni bileşikler ve metotlar.
ES2191341T3 (es)	2003-09-01	Derivados de la 2-fenoxianilina.
DE60115569D1 (de)	2006-01-12	Phenoxazinanaloge zur Behandlung von Amyloidose
CA2285535A1 (en)	1998-11-12	Benzimidazole derivative for treating allergy-related disease
ATE277887T1 (de)	2004-10-15	Verfahren zur herstellung von 1,4-bis((2- (dimethylamino)ethyl amino)-5,8- dihydroxyanthracene-9,10-dion
DE59604901D1 (de)	2000-05-11	Carbamoylcarbonsäureamide
ATE267018T1 (de)	2004-06-15	Verwendung von peptidverbindungen zur behandlung von sle
RU2365594C2 (ru)	2009-08-27	Применение циклических пептидов анабенопептинового типа для лечения состояния, при котором полезно ингибирование карбоксипептидазы u, новые анабенопептиновые производные и их промежуточные соединения

Legal Events

Date

Code

Title

Description

2006-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1193260

Country of ref document: EP

2008-06-15

REN

Ceased due to non-payment of the annual fee